Genovese Burford & Brothers Wealth & Retirement Plan Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-180
Closed -$15K 249
2018
Q2
$15K Hold
180
0.01% 281
2018
Q1
$14K Hold
180
0.01% 290
2017
Q4
$16K Buy
+180
New +$14.4K 0.04% 159
2017
Q3
Sell
-26
Closed -$2K 409
2017
Q2
$2K Hold
26
﹤0.01% 360
2017
Q1
$3K Sell
26
-143
-85% -$11.2K ﹤0.01% 380
2016
Q4
$13K Sell
169
-672
-80% -$52.8K ﹤0.01% 293
2016
Q3
$72K Hold
841
0.03% 127
2016
Q2
$72K Buy
841
+81
+11% +$6.55K 0.03% 116
2016
Q1
$57K Buy
760
+26
+4% +$1.96K 0.03% 117
2015
Q4
$56K Buy
+734
New +$55.3K 0.03% 121

Other funds holding MDT

Genovese Burford & Brothers Wealth & Retirement Plan Management's MDT Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Medtronic (MDT) in Q3 2018, closing a stake of 180 shares — an estimated $15K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in MDT in Q4 2015 and held it in 10 quarters. The position peaked at $72K in Q3 2016. 1,485 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Medtronic position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 180 Medtronic shares in Q3 2018, an estimated $15K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Medtronic in Q4 2015 and held it in 10 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Medtronic position peaked at $72K in Q3 2016.
  • 1,485 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.